Target intelligence / Profile preview

Family with sequence similarity 215 member B (FAM215B)

Target
FAM215B
Molecular classification
Other (long non-coding RNA)
01

Overview

Family with sequence similarity 215 member B (FAM215B), also known as ARL17A-IT1, is a human long non-coding RNA gene defined as a non-protein-coding transcript located within the ARL17A gene locus[1][3]. Unlike ARL17A, which encodes an ADP-ribosylation factor-like GTPase involved in intracellular vesicle transport, FAM215B itself does not encode a functional protein and is classified as a long intergenic non-coding RNA (lincRNA)[1][7]. Recent computational studies have implicated FAM215B in competing endogenous RNA (ceRNA) networks, suggesting a possible indirect regulatory role in diseases such as gout, via modulation of gene expression, but no experimentally validated biological function or therapeutic application has been established[7]. FAM215B is not recognized as a receptor, enzyme, transporter, or other classical therapeutic target, and there is no evidence of drug interaction or direct involvement in established pathological processes. Information about FAM215B remains limited, with current data primarily from bioinformatics analyses or gene annotation databases rather than functional studies.

Other names
ARL17A-IT1ARL17A intronic transcript 1 (non-protein coding)[1][3]
02

Mechanism of action

None established; as a non-protein-coding transcript, therapeutic mechanisms targeting it have not been reported[1][7]

03

Biological functions

Potentially regulatory as a long non-coding RNA (lncRNA), may act in gene expression regulation[7]Can participate in cell signaling regulatory networks, including ceRNA crosstalk[7]
04

Disease associations

Other (reported association with gout via regulatory ceRNA networks)[7]No confirmed direct role in major diseases; evidence is based on computational or association studies and not functional validation
05

Safety considerations

None reported or known; as an lncRNA, it is not a direct druggable target
06

Interacting drugs

None known specific to FAM215B
07

Biomarkers

None validated for clinical use

Beyond the preview

Go deeper on Family with sequence similarity 215 member B (FAM215B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 215 member B (FAM215B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call